No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2741027 |
chr2:234518011-234518012 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs574620703 |
chr2:234518030-234518031 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs540044223 |
chr2:234518033-234518034 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs373539556 |
chr2:234518076-234518077 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs188681643 |
chr2:234518080-234518081 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs546288782 |
chr2:234518104-234518105 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs17863758 |
chr2:234518109-234518110 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs562884343 |
chr2:234518110-234518111 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs574773201 |
chr2:234518123-234518124 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs80337635 |
chr2:234518137-234518138 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs17864667 |
chr2:234518166-234518167 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs567060258 |
chr2:234521706-234521707 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs561286013 |
chr2:234521728-234521729 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs539233844 |
chr2:234521823-234521824 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs557928422 |
chr2:234521862-234521863 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs563201298 |
chr2:234524019-234524020 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs193062305 |
chr2:234524035-234524036 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs561497636 |
chr2:234525344-234525345 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs10210058 |
chr2:234525355-234525356 |
Inactive region
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
20 |
rs148981671 |
chr2:234525448-234525449 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs373865399 |
chr2:234525522-234525523 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs570664217 |
chr2:234525562-234525563 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs183078816 |
chr2:234525599-234525600 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs550048511 |
chr2:234525600-234525601 |
Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs367633546 |
chr2:234525618-234525619 |
Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs570122405 |
chr2:234525626-234525627 |
Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs45576241 |
chr2:234525631-234525632 |
Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs186450852 |
chr2:234525639-234525640 |
Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs573523307 |
chr2:234525654-234525655 |
Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs575605726 |
chr2:234525700-234525701 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs71423605 |
chr2:234525710-234525711 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs565705061 |
chr2:234525747-234525748 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs45586436 |
chr2:234525760-234525761 |
Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs558023639 |
chr2:234525761-234525762 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs577854776 |
chr2:234525795-234525796 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs543977941 |
chr2:234525813-234525814 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs4114768 |
chr2:234525824-234525825 |
Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
38 |
rs113910749 |
chr2:234525868-234525869 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs529035590 |
chr2:234525876-234525877 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs576107211 |
chr2:234525893-234525894 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs541526041 |
chr2:234525978-234525979 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs189645806 |
chr2:234525986-234525987 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs527937689 |
chr2:234526035-234526036 |
Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs116655560 |
chr2:234526046-234526047 |
Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs548002226 |
chr2:234526130-234526131 |
Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs148224012 |
chr2:234526131-234526132 |
Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs373737548 |
chr2:234526150-234526151 |
Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs11415286 |
chr2:234526223-234526224 |
Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs78219233 |
chr2:234526224-234526225 |
Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs397988271 |
chr2:234526237-234526238 |
Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|